Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 452

1.

Do equivalent doses of escitalopram and citalopram have similar efficacy? A pooled analysis of two positive placebo-controlled studies in major depressive disorder.

Lepola U, Wade A, Andersen HF.

Int Clin Psychopharmacol. 2004 May;19(3):149-55. Erratum in: Int Clin Psychopharmacol. 2004 Jul;19(4):255.

PMID:
15107657
[PubMed - indexed for MEDLINE]
2.

[Escitalopram is more effective than citalopram for the treatment of severe major depressive disorder].

Azorin JM, Llorca PM, Despiegel N, Verpillat P.

Encephale. 2004 Mar-Apr;30(2):158-66. French.

PMID:
15107719
[PubMed - indexed for MEDLINE]
3.

Efficacy and tolerability of escitalopram versus citalopram in major depressive disorder: a 6-week, multicenter, prospective, randomized, double-blind, active-controlled study in adult outpatients.

Yevtushenko VY, Belous AI, Yevtushenko YG, Gusinin SE, Buzik OJ, Agibalova TV.

Clin Ther. 2007 Nov;29(11):2319-32.

PMID:
18158074
[PubMed - indexed for MEDLINE]
4.

Double-blind comparison of escitalopram and duloxetine in the acute treatment of major depressive disorder.

Khan A, Bose A, Alexopoulos GS, Gommoll C, Li D, Gandhi C.

Clin Drug Investig. 2007;27(7):481-92.

PMID:
17563128
[PubMed - indexed for MEDLINE]
5.

Escitalopram (10-20 mg/day) is effective and well tolerated in a placebo-controlled study in depression in primary care.

Lepola UM, Loft H, Reines EH.

Int Clin Psychopharmacol. 2003 Jul;18(4):211-7.

PMID:
12817155
[PubMed - indexed for MEDLINE]
6.

Escitalopram (S-enantiomer of citalopram): clinical efficacy and onset of action predicted from a rat model.

Montgomery SA, Loft H, Sánchez C, Reines EH, Papp M.

Pharmacol Toxicol. 2001 May;88(5):282-6.

PMID:
11393591
[PubMed - indexed for MEDLINE]
7.

A comparative study of the efficacy of long-term treatment with escitalopram and paroxetine in severely depressed patients.

Boulenger JP, Huusom AK, Florea I, Baekdal T, Sarchiapone M.

Curr Med Res Opin. 2006 Jul;22(7):1331-41.

PMID:
16834832
[PubMed - indexed for MEDLINE]
8.

A randomized, double-blind, 24-week study of escitalopram (10 mg/day) versus citalopram (20 mg/day) in primary care patients with major depressive disorder.

Colonna L, Andersen HF, Reines EH.

Curr Med Res Opin. 2005 Oct;21(10):1659-68.

PMID:
16238906
[PubMed - indexed for MEDLINE]
9.

[Milnacipran and venlafaxine at flexible doses (up to 200 mg/d) in the outpatient treatment of adults with moderate-to-severe major depressive disorder: a 24-week randomised, double blind exploratory study].

Olié JP, Gourion D, Montagne A, Rostin M, Poirier MF.

Encephale. 2009 Dec;35(6):595-604. doi: 10.1016/j.encep.2009.10.011. Epub . French.

PMID:
20004291
[PubMed - indexed for MEDLINE]
10.
11.

Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.

Clayton AH, Croft HA, Horrigan JP, Wightman DS, Krishen A, Richard NE, Modell JG.

J Clin Psychiatry. 2006 May;67(5):736-46.

PMID:
16841623
[PubMed - indexed for MEDLINE]
12.

Efficacy of escitalopram in patients with severe depression: a pooled analysis.

Llorca PM, Azorin JM, Despiegel N, Verpillat P.

Int J Clin Pract. 2005 Mar;59(3):268-75.

PMID:
15857321
[PubMed - indexed for MEDLINE]
13.

The effect of escitalopram on sleep problems in depressed patients.

Lader M, Andersen HF, Baekdal T.

Hum Psychopharmacol. 2005 Jul;20(5):349-54.

PMID:
15912558
[PubMed - indexed for MEDLINE]
14.

Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.

Moore N, Verdoux H, Fantino B.

Int Clin Psychopharmacol. 2005 May;20(3):131-7.

PMID:
15812262
[PubMed - indexed for MEDLINE]
15.

Efficacy of escitalopram in the treatment of major depressive disorder compared with conventional selective serotonin reuptake inhibitors and venlafaxine XR: a meta-analysis.

Kennedy SH, Andersen HF, Lam RW.

J Psychiatry Neurosci. 2006 Mar;31(2):122-31. Erratum in: J Psychiatry Neurosci. 2006 Jul;31(4):228.

PMID:
16575428
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Venlafaxine extended release versus citalopram in patients with depression unresponsive to a selective serotonin reuptake inhibitor.

Lenox-Smith AJ, Jiang Q.

Int Clin Psychopharmacol. 2008 May;23(3):113-9. doi: 10.1097/YIC.0b013e3282f424c2.

PMID:
18408525
[PubMed - indexed for MEDLINE]
17.

Escitalopram versus SNRI antidepressants in the acute treatment of major depressive disorder: integrative analysis of four double-blind, randomized clinical trials.

Kornstein SG, Li D, Mao Y, Larsson S, Andersen HF, Papakostas GI.

CNS Spectr. 2009 Jun;14(6):326-33.

PMID:
19668123
[PubMed - indexed for MEDLINE]
18.

[Escitalopram for treatment of major depressive disorder in adults].

Llorca PM, Brousse G, Schwan R.

Encephale. 2005 Jul-Aug;31(4 Pt 1):490-501. Review. French.

PMID:
16389716
[PubMed - indexed for MEDLINE]
19.

Effective dose of escitalopram in moderate versus severe DSM-IV major depression.

Bech P, Andersen HF, Wade A.

Pharmacopsychiatry. 2006 Jul;39(4):128-34.

PMID:
16871468
[PubMed - indexed for MEDLINE]
20.

Randomized placebo-controlled trial of escitalopram and venlafaxine XR in the treatment of generalized anxiety disorder.

Bose A, Korotzer A, Gommoll C, Li D.

Depress Anxiety. 2008;25(10):854-61.

PMID:
18050245
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk